<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">MSJ</journal-id>
<journal-id journal-id-type="hwp">spmsj</journal-id>
<journal-id journal-id-type="nlm-ta">Mult Scler</journal-id>
<journal-title>Multiple Sclerosis Journal</journal-title>
<issn pub-type="ppub">1352-4585</issn>
<issn pub-type="epub">1477-0970</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1352458511418144</article-id>
<article-id pub-id-type="publisher-id">10.1177_1352458511418144</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letter to the Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Response to the letter of Villar et al. ‘Quantitative and qualitative IgM analysis in CSF’</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Reiber</surname><given-names>Hansotto</given-names></name>
<xref ref-type="aff" rid="aff1-1352458511418144">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Rostasy</surname><given-names>Kevin</given-names></name>
<xref ref-type="aff" rid="aff2-1352458511418144">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-1352458511418144"><label>1</label>Neurochemistry Laboratory, University Göttingen, Germany.</aff>
<aff id="aff2-1352458511418144"><label>2</label>Department of Pediatrics IV, Division of Pediatric Neurology and Inherited Metabolic Diseases, University Innsbruck, Austria.</aff>
<author-notes>
<corresp id="corresp1-1352458511418144">Dr Kevin Rostasy, Department of Pediatrics IV, Division of Pediatric Neurology and Inherited Metabolic Diseases, University Innsbruck, Anichstrasse 35, Innsbruck A-6020, Austria Email: <email>kevin.rostasy@uki.at</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>2</month>
<year>2012</year>
</pub-date>
<volume>18</volume>
<issue>2</issue>
<fpage>252</fpage>
<lpage>253</lpage>
<permissions>
<copyright-statement>© SAGE Publications 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>The detection of oligoclonal IgG is definitely the most sensitive method to detect an intrathecal IgG synthesis in multiple sclerosis (MS) patients. However, Villar et al. should not mix up the quality of this well-characterized and established analysis for oligoclonal IgG with that of the method for oligoclonal IgM which is far from generally accepted and has been disputed for 30 years, which is also investigated in our laboratory.<sup><xref ref-type="bibr" rid="bibr1-1352458511418144">1</xref></sup> There is a basic difference: oligoclonal IgG bands in the isoelectric focusing (IEF) are referring to antibodies from single-cell clones with different isoelectric points due to the individual intracellular, post-transitional modifications; in contrast ‘oligoclonal’ IgM, the cellular pentameric antibodies which are for analysis dissociated to the non-equally modified monomers, lose the association with single-cell clones, i.e. bands in IEF representing an arbitrary accumulation of equally charged antibodies from different clones.</p>
<p>The quantitative method for the detection of intrathecal IgM synthesis refers to a reference range based on clinically defined group of 4,300 patients without an intrathecal humoral immune response.<sup><xref ref-type="bibr" rid="bibr2-1352458511418144">2</xref></sup> <xref ref-type="fig" rid="fig1-1352458511418144">Figure 1</xref> shows the corresponding diagram (cerebrospinal fluid (CSF)/serum concentration quotients, <italic>Q</italic><sub>IgM</sub> versus <italic>Q</italic><sub>Alb</sub>, the albumin quotient) with a hyperbolic reference range.<sup><xref ref-type="bibr" rid="bibr2-1352458511418144">2</xref></sup></p>
<fig id="fig1-1352458511418144" position="float">
<label>Figure 1.</label>
<caption>
<p>Control group of patients without an intrathecal humoral immune response.<sup><xref ref-type="bibr" rid="bibr2-1352458511418144">2</xref></sup></p></caption>
<graphic xlink:href="10.1177_1352458511418144-fig1.tif"/>
</fig>
<p>The reference to a statistically defined reference range is a quantitative method (not semi-quantitative as Villar et al. mistakenly state). The clinical sensitivity for the detection of an intrathecal IgM synthesis in quotient diagrams depends on the allowed standard deviation (SD) around the mean. This of course must have an influence on the specificity. To reach a maximal specificity for diagnostic purposes we used the range of <italic>Q</italic><sub>mean</sub> ± 3 SD (<xref ref-type="fig" rid="fig2-1352458511418144">Figure 2</xref>), that means that about 99% of the controls are inside the reference range (quotient diagrams used for routine analysis). For the comparison of groups we introduced now a less specific but more sensitive reference range for <italic>Q</italic><sub>mean</sub> ± 2 SD (still including 96% of the controls in the reference range) (<xref ref-type="fig" rid="fig2-1352458511418144">Figure 2</xref>). This allowed the integration of young children with a weaker intrathecal IgM response in the statistical comparison of age-related variations in MS.<sup><xref ref-type="bibr" rid="bibr3-1352458511418144">3</xref>,<xref ref-type="bibr" rid="bibr4-1352458511418144">4</xref></sup> As shown in <xref ref-type="fig" rid="fig2-1352458511418144">Figure 2</xref> of Stauch et al.<sup><xref ref-type="bibr" rid="bibr4-1352458511418144">4</xref></sup> for the method comparison between qualitative and quantitative IgM results, three of the IgM quotients measured by Villar et al. are around or below the mean <italic>Q</italic><sub>IgM</sub> of the controls, i.e. they have a very high probability to be normal or to be without an intrathecal IgM synthesis. These kinds of values are shown, e.g., in a group of psychiatric control patients without any humoral immune response (see <xref ref-type="fig" rid="fig1-1352458511418144">Figure 1c</xref> in Bechter et al.<sup><xref ref-type="bibr" rid="bibr5-1352458511418144">5</xref></sup>).</p>
<fig id="fig2-1352458511418144" position="float">
<label>Figure 2.</label>
<caption><p>Reference range of IgG quotients based on a <italic>Q</italic><sub>mean</sub> ± 3 SD (diagnostic application) and with <italic>Q</italic><sub>mean</sub> ± 2 SD (statistic application).<sup><xref ref-type="bibr" rid="bibr3-1352458511418144">3</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr5-1352458511418144">5</xref></sup></p></caption>
<graphic xlink:href="10.1177_1352458511418144-fig2.tif"/>
</fig>
<p>There is no doubt that a sufficiently sensitive qualitative method (oligoclonal IgG) helps to increase the sensitivity for the detection of an intrathecal synthesis. In the range of a weak intrathecal response, often in the range of the upper reference limit (<italic>Q</italic><sub>lim</sub> in <xref ref-type="fig" rid="fig2-1352458511418144">Figure 2</xref>), but we detected them not in the range of or below <italic>Q</italic><sub>mean</sub> (IgG) in thousands of samples analysed.</p>
<p>Five of the possibly false-positive IgM interpretations of Villar et al. by oligoclonal IgM, as indicated in <xref ref-type="fig" rid="fig2-1352458511418144">Figure 2</xref> of Stauch et al.,<sup><xref ref-type="bibr" rid="bibr4-1352458511418144">4</xref></sup> are in the range of high blood derived IgM fractions in CSF recognized by their high <italic>Q</italic><sub>Alb</sub> values (slight barrier dysfunction). This represents another argument for a possible bias in the method for oligoclonal IgM, as it means that for the higher CSF IgM concentration the probability of a false interpretation as intrathecal synthesis is increased.</p>
<p>The one patient of Villar et al. which we stated as false-negative (the open circle in <xref ref-type="fig" rid="fig2-1352458511418144">Figure 2</xref> of Stauch et al.<sup><xref ref-type="bibr" rid="bibr4-1352458511418144">4</xref></sup>) is demonstrated in the quotient diagram with calculated 20% intrathecal IgM synthesis, clearly above the reference range and thus has a statistical probability of &gt;99.5% to be not normal in contrast to the qualitative analysis. However, in this case an analytical imprecision in immunochemical nephelometry could be considered as an alternative to explain the discrepancy.</p>
<p>To control their method Villar et al. should compare other clinically defined patient groups such as Guillain–Barré polyradiculitis with a barrier dysfunction but without a humoral immune response. In general, the sensitivity of their oligoclonal IgM method can be detected by a serial dilution experiment of a CSF sample with high intrathecal IgM fraction in CSF.</p>
<p>We understand that a statistical method is not a proof for the individual patient, but it is still a fundamental method to compare groups and to judge probabilities of interpretations.</p>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="bibr1-1352458511418144">
<label>1.</label>
<citation citation-type="thesis">
<person-group person-group-type="author">
<name><surname>Boeer</surname><given-names>A</given-names></name>
</person-group>. <source>Qualitative und quantitative Untersuchungen zum Immunglobulin M(IgM) im Liquor cerebrospinalis und Blut</source>. <comment>Dissertation, Medical Faculty</comment>, <publisher-name>Georg August University Goettingen</publisher-name>, <year>1989</year>.</citation>
</ref>
<ref id="bibr2-1352458511418144">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Reiber</surname><given-names>H</given-names></name>
</person-group>. <article-title>Flow rate of cerebrospinal fluid (CSF)—a concept common to normal blood–CSF barrier function and to dysfunction in neurological diseases</article-title>. <source>J Neurol Sci</source> <year>1994</year>; <volume>122</volume>: <fpage>189</fpage>–<lpage>203</lpage>.</citation>
</ref>
<ref id="bibr3-1352458511418144">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Reiber</surname><given-names>H</given-names></name>
<name><surname>Teut</surname><given-names>M</given-names></name>
<name><surname>Pohl</surname><given-names>D</given-names></name>
<name><surname>Rostasy</surname><given-names>KM</given-names></name>
<name><surname>Hanefeld</surname><given-names>F</given-names></name>
</person-group>. <article-title>Paediatric and adult multiple sclerosis: age related differences and time course of the neuroimmunological response in cerebrospinal fluid</article-title>. <source>Mult Scler</source> <year>2009</year>; <volume>15</volume>: <fpage>1466</fpage>–<lpage>1480</lpage>.</citation>
</ref>
<ref id="bibr4-1352458511418144">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stauch</surname><given-names>C</given-names></name>
<name><surname>Reiber</surname><given-names>H</given-names></name>
<name><surname>Rauchenzauner</surname><given-names>M</given-names></name>
<name><surname>Pohl</surname><given-names>D</given-names></name>
<name><surname>Hanefeld</surname><given-names>F</given-names></name>
<name><surname>Gärtner</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>Intrathecal IgM synthesis in pediatric MS is not a negative prognostic marker of disease progression: Quantitative versus qualitative IgM analysis</article-title>. <source>Mult Scler</source> <year>2010</year>; DOI: 10.1177/1352458510388543<pub-id pub-id-type="doi">10.1177/1352458510388543</pub-id>.</citation>
</ref>
<ref id="bibr5-1352458511418144">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bechter</surname><given-names>K</given-names></name>
<name><surname>Reiber</surname><given-names>H</given-names></name>
<name><surname>Herzog</surname><given-names>S</given-names></name>
<name><surname>Fuchs</surname><given-names>D</given-names></name>
<name><surname>Tumani</surname><given-names>H</given-names></name>
<name><surname>Maxeiner</surname><given-names>HG</given-names></name>
</person-group>. <article-title>Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders. Identification of subgroups with immune responses and blood–CSF barrier dysfunction</article-title>. <source>J Psychiatric Res</source> <year>2010</year>; <volume>44</volume>: <fpage>321</fpage>–<lpage>330</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>